Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin.

Subjects

Subjects :

Humans
Hypoglycemic Agents
Glucose
Sodium
Diabetes Mellitus, Type 2
Metformin
Sodium-Glucose Transporter 2 Inhibitors adverse effects
Cardiovascular Diseases chemically induced

Details

Language :

English

ISSN :

1539-3704

Volume :

175

Issue :

12

Database :

MEDLINE

Journal :

Annals of internal medicine

Publication Type :

Academic Journal

Accession number :

36534995

Full Text :

https://doi.org/10.7326/L22-0333